Variant report

Variant	esv3524227
Chromosome Location	chr4:21949654-21951752
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:76)
CpG islands
(count:612)
Chromatin interactive
region (count:0)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:76 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr4:21949958-21950354	H1-hESC	embryonic stem cell:	n/a	n/a
2	CHD2	chr4:21949928-21950234	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTBP2	chr4:21950634-21951259	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr4:21950376-21950460	GM20000	blood:	n/a	n/a
5	CTCF	chr4:21950306-21950514	HepG2	liver:	n/a	n/a
6	CTCF	chr4:21950381-21950425	LNCaP	prostate:	n/a	n/a
7	CTCF	chr4:21950120-21950270	AG04449	skin:	n/a	n/a
8	CTCF	chr4:21950340-21950490	HAc	cerebellar:	n/a	n/a
9	CTCF	chr4:21950380-21950530	WERI-Rb-1	eye:	n/a	n/a
10	CTCF	chr4:21950406-21950418	HepG2	liver:	n/a	n/a
11	CTCF	chr4:21950345-21950458	SK-N-SH_RA	brain:	n/a	n/a
12	CTCF	chr4:21950320-21950470	GM12868	blood:	n/a	n/a
13	CTCF	chr4:21950364-21950482	LNCaP	prostate:	n/a	n/a
14	CTCF	chr4:21950300-21950450	HRPEpiC	eye:	n/a	n/a
15	CTCF	chr4:21950433-21950450	HepG2	liver:	n/a	n/a
16	CTCF	chr4:21950320-21950470	HepG2	liver:	n/a	n/a
17	CTCF	chr4:21950300-21950450	AG09319	gingival:	n/a	n/a
18	CTCF	chr4:21950312-21950567	H1-hESC	embryonic stem cell:	n/a	n/a
19	CTCF	chr4:21950356-21950470	NHEK	skin:	n/a	n/a
20	CTCF	chr4:21949940-21950090	BJ	skin:	n/a	n/a
21	CTCF	chr4:21950360-21950510	HMEC	breast:	n/a	n/a
22	CTCF	chr4:21950280-21950430	GM12865	blood:	n/a	n/a
23	CTCF	chr4:21950140-21950290	AoAF	blood vessel:	n/a	n/a
24	CTCF	chr4:21950100-21950250	HBMEC	blood vessel:	n/a	n/a
25	CTCF	chr4:21950243-21950532	H1-hESC	embryonic stem cell:	n/a	n/a
26	CTCF	chr4:21950320-21950470	HA-sp	spinal cord:	n/a	n/a
27	CTCF	chr4:21950346-21950479	ProgFib	skin:	n/a	n/a
28	CTCF	chr4:21950300-21950450	AG09309	skin:	n/a	n/a
29	CTCF	chr4:21950340-21950490	HRPEpiC	eye:	n/a	n/a
30	CTCF	chr4:21950560-21950710	AG09319	gingival:	n/a	chr4:21950602-21950620 chr4:21950604-21950617
31	CTCF	chr4:21950082-21950250	Fibrobl	skin:	n/a	n/a
32	CTCF	chr4:21949895-21951210	SK-N-SH	brain:	n/a	chr4:21950602-21950620 chr4:21950604-21950617
33	CTCF	chr4:21950180-21950430	AG04449	skin:	n/a	n/a
34	CTCF	chr4:21950600-21950750	HMEC	breast:	n/a	chr4:21950602-21950620 chr4:21950604-21950617
35	CTCF	chr4:21950300-21950450	HMF	breast:	n/a	n/a
36	CTCF	chr4:21950322-21950496	Pancreas_OC	pancreas:	n/a	n/a
37	CTCF	chr4:21950140-21950290	HAc	cerebellar:	n/a	n/a
38	CTCF	chr4:21950376-21950463	Medullo	brain:	n/a	n/a
39	CTCF	chr4:21950220-21950370	BJ	skin:	n/a	n/a
40	CTCF	chr4:21950320-21950470	GM12872	blood:	n/a	n/a
41	CTCF	chr4:21950320-21950470	SK-N-SH_RA	brain:	n/a	n/a
42	CTCF	chr4:21950300-21950450	HEK293	kidney:	n/a	n/a
43	CTCF	chr4:21950760-21950910	WERI-Rb-1	eye:	n/a	n/a
44	CTCF	chr4:21950320-21950470	WERI-Rb-1	eye:	n/a	n/a
45	CTCF	chr4:21950280-21950430	AG09319	gingival:	n/a	n/a
46	CTCF	chr4:21950400-21950444	Kidney_OC	kidney:	n/a	n/a
47	CTCF	chr4:21950340-21950490	GM12866	blood:	n/a	n/a
48	CTCF	chr4:21950380-21950530	AoAF	blood vessel:	n/a	n/a
49	CTCF	chr4:21950300-21950450	HBMEC	blood vessel:	n/a	n/a
50	CTCF	chr4:21950260-21950488	Fibrobl	skin:	n/a	n/a

(count:612 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:21950722-21950772	GM12892	blood:	n/a
2	chr4:21949853-21949903	AG04450	lung:	fetal
3	chr4:21950722-21950772	GM12892	blood:	n/a
4	chr4:21949853-21949903	AG04450	lung:	fetal
5	chr4:21950864-21950914	HRCEpiC	kidney:	n/a
6	chr4:21949853-21949903	GM12878	blood:	n/a
7	chr4:21950952-21951002	GM12891	blood:	n/a
8	chr4:21950952-21951002	HEEpiC	esophagus:	n/a
9	chr4:21950307-21950357	GM12892	blood:	n/a
10	chr4:21950952-21951002	Jurkat	blood:	n/a
11	chr4:21950864-21950914	PrEC	prostate:	n/a
12	chr4:21951046-21951096	PFSK-1	brain:	n/a
13	chr4:21950766-21950816	GM12891	blood:	n/a
14	chr4:21950766-21950816	HepG2	liver:	n/a
15	chr4:21949853-21949903	HepG2	liver:	n/a
16	chr4:21950307-21950357	HIPEpiC	eye:	n/a
17	chr4:21950307-21950357	HCPEpiC	choroid plexus:	n/a
18	chr4:21950567-21950617	SKMC	muscle:	n/a
19	chr4:21950722-21950772	HL-60	blood:	n/a
20	chr4:21950567-21950617	Hela-S3	cervix:	n/a
21	chr4:21951046-21951096	SK-N-SH_RA	brain:	n/a
22	chr4:21950155-21950205	ovcar-3	ovarian:	n/a
23	chr4:21950952-21951002	Caco-2	colon:	n/a
24	chr4:21950155-21950205	PANC-1	pancreas:	n/a
25	chr4:21950155-21950205	GM19239	blood:	n/a
26	chr4:21950567-21950617	Caco-2	colon:	n/a
27	chr4:21950766-21950816	HRCEpiC	kidney:	n/a
28	chr4:21949853-21949903	HCM	heart:	n/a
29	chr4:21950567-21950617	ovcar-3	ovarian:	n/a
30	chr4:21951046-21951096	Hepatocyte	liver:	n/a
31	chr4:21950155-21950205	K562	blood:	n/a
32	chr4:21950766-21950816	HCPEpiC	choroid plexus:	n/a
33	chr4:21950307-21950357	A549	lung:	n/a
34	chr4:21951046-21951096	HRE	kidney:	n/a
35	chr4:21950722-21950772	HUVEC	blood vessel:	n/a
36	chr4:21950567-21950617	HEEpiC	esophagus:	n/a
37	chr4:21950307-21950357	GM12878	blood:	n/a
38	chr4:21950567-21950617	BE2_C	brain:	n/a
39	chr4:21950155-21950205	Jurkat	blood:	n/a
40	chr4:21950952-21951002	HRE	kidney:	n/a
41	chr4:21950173-21950223	HNPCEpiC	eye:	n/a
42	chr4:21950307-21950357	HRCEpiC	kidney:	n/a
43	chr4:21950722-21950772	HNPCEpiC	eye:	n/a
44	chr4:21951046-21951096	NHDF-neo	bronchial:	n/a
45	chr4:21950307-21950357	SK-N-SH	brain:	n/a
46	chr4:21950864-21950914	PFSK-1	brain:	n/a
47	chr4:21950307-21950357	PFSK-1	brain:	n/a
48	chr4:21950952-21951002	HAEpiC	amniotic membrane:	n/a
49	chr4:21950766-21950816	T-47D	breast:	n/a
50	chr4:21950952-21951002	HIPEpiC	eye:	n/a

No data

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PACRGL-5	chr4:21950638-21951082	ENSG00000250039.3
2	lnc-PACRGL-5	chr4:21950638-21951082	ENSG00000250039.2

No data

Variant related genes	Relation type
KCNIP4	TF binding region
ENSG00000250039	TF binding region
KCNIP4	CpG island
ENSG00000250039	CpG island

Extended variants
information (count: 65 )
Associated
traits (count: 57 )

Variant overlapped rSNPs/rCNVs (count:65 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs528420350	chr4:21949744-21949745	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs539423083	chr4:21949771-21949772	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs547017709	chr4:21949776-21949777	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs117418471	chr4:21949793-21949794	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs532870463	chr4:21949836-21949837	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs183419966	chr4:21949845-21949846	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs569443346	chr4:21949857-21949858	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
8	rs553359738	chr4:21949880-21949881	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
9	rs536849912	chr4:21949883-21949884	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs554659706	chr4:21949936-21949937	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs559413664	chr4:21949949-21949950	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs566618548	chr4:21950012-21950013	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs533762125	chr4:21950053-21950054	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs558559136	chr4:21950092-21950093	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs577039754	chr4:21950108-21950109	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs369150791	chr4:21950152-21950153	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs556199166	chr4:21950162-21950163	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs138344733	chr4:21950170-21950171	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
19	rs201122019	chr4:21950174-21950175	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs199807375	chr4:21950180-21950181	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs368789449	chr4:21950187-21950188	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
22	rs373008352	chr4:21950190-21950191	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs377005581	chr4:21950239-21950240	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs370406619	chr4:21950240-21950241	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs6448102	chr4:21950259-21950260	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs376702112	chr4:21950289-21950290	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs370842675	chr4:21950298-21950299	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs369688019	chr4:21950317-21950318	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
29	rs565256963	chr4:21950336-21950337	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
30	rs371751955	chr4:21950383-21950384	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs551217400	chr4:21950392-21950393	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs569577305	chr4:21950396-21950397	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs530313892	chr4:21950397-21950398	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs149211629	chr4:21950414-21950415	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs566558867	chr4:21950513-21950514	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs533917192	chr4:21950521-21950522	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs558389654	chr4:21950570-21950571	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
38	rs28562547	chr4:21950626-21950627	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs537452772	chr4:21950766-21950767	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
40	rs555991285	chr4:21950785-21950786	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
41	rs146934297	chr4:21950818-21950819	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
42	rs186648075	chr4:21950841-21950842	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
43	rs535260010	chr4:21950910-21950911	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
44	rs2009195	chr4:21951004-21951005	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
45	rs571933215	chr4:21951010-21951011	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
46	rs114107456	chr4:21951032-21951033	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
47	rs137861343	chr4:21951047-21951048	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
48	rs373979232	chr4:21951196-21951197	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs192439056	chr4:21951228-21951229	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs543658014	chr4:21951256-21951257	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:57)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Breast cancer	17603634	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
Oral squamous cell carcinoma	17134496	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21785460	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21858162	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Breast cancer	17133270	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	22183965	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Olfactory neuroblastoma	18408657	CNVD
Burkitt''s lymphoma	20823134	CNVD
Burkitt''s lymphoma	19759907	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	16774939	CNVD
Cancer	22183965	CNVD
Gastric cancer	16891809	CNVD

Chromatin state (count:227 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:21947600-21950800	Active TSS	Brain Inferior Temporal Lobe	brain
2	chr4:21948000-21951400	Active TSS	Brain Anterior Caudate	brain
3	chr4:21948600-21950000	Bivalent/Poised TSS	Brain Angular Gyrus	brain
4	chr4:21948600-21950000	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
5	chr4:21948800-21950800	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
6	chr4:21948800-21951000	Active TSS	Ovary	ovary
7	chr4:21949200-21949800	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
8	chr4:21949200-21950000	Bivalent/Poised TSS	Colon Smooth Muscle	Colon
9	chr4:21949200-21951200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
10	chr4:21949400-21949800	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
11	chr4:21949400-21949800	Bivalent/Poised TSS	Fetal Brain Female	brain
12	chr4:21949400-21951000	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
13	chr4:21949400-21951000	Bivalent/Poised TSS	Brain Substantia Nigra	brain
14	chr4:21949400-21951200	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
15	chr4:21949400-21951200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
16	chr4:21949600-21949800	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr4:21949600-21949800	Flanking Bivalent TSS/Enh	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr4:21949600-21949800	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
19	chr4:21949600-21949800	Flanking Bivalent TSS/Enh	Fetal Brain Male	brain
20	chr4:21949600-21949800	Bivalent Enhancer	Fetal Heart	heart
21	chr4:21949600-21949800	Bivalent/Poised TSS	Fetal Muscle Trunk	muscle
22	chr4:21949600-21949800	Flanking Bivalent TSS/Enh	Fetal Stomach	stomach
23	chr4:21949600-21949800	Bivalent/Poised TSS	Rectal Smooth Muscle	rectum
24	chr4:21949600-21950000	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
25	chr4:21949600-21950000	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
26	chr4:21949600-21950000	Bivalent Enhancer	Primary hematopoietic stem cells	blood
27	chr4:21949600-21950000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
28	chr4:21949600-21950000	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
29	chr4:21949600-21950000	Bivalent/Poised TSS	Fetal Kidney	kidney
30	chr4:21949600-21950000	Bivalent Enhancer	Fetal Lung	lung
31	chr4:21949600-21950000	Bivalent Enhancer	Fetal Muscle Leg	muscle
32	chr4:21949600-21950000	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
33	chr4:21949600-21950200	Bivalent Enhancer	Fetal Thymus	thymus
34	chr4:21949600-21950400	Bivalent/Poised TSS	Duodenum Mucosa	Duodenum
35	chr4:21949600-21951000	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
36	chr4:21949600-21951000	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
37	chr4:21949600-21951000	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
38	chr4:21949600-21951000	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
39	chr4:21949600-21951200	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
40	chr4:21949600-21951200	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
41	chr4:21949600-21951200	Bivalent/Poised TSS	Duodenum Smooth Muscle	Duodenum
42	chr4:21949600-21951400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
43	chr4:21949800-21950000	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
44	chr4:21949800-21950000	Flanking Bivalent TSS/Enh	H9 Derived Neuron Cultured Cells	ES cell derived
45	chr4:21949800-21950000	Bivalent/Poised TSS	iPS DF 19.11 Cell Line	embryonic stem cell
46	chr4:21949800-21950000	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr4:21949800-21950000	Flanking Bivalent TSS/Enh	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
48	chr4:21949800-21950000	Bivalent Enhancer	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
49	chr4:21949800-21950000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
50	chr4:21949800-21950000	Bivalent/Poised TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links